Caricamento...
Stem cells and regenerative therapies for Parkinson’s disease
Currently the mainstay of Parkinson’s disease (PD) therapy is the pharmacological replacement of the loss of the dopaminergic nigrostriatal pathway using drugs such as dopamine agonists and levodopa. Whilst these drugs effectively ameliorate some of the motor features of PD, they do not improve many...
Salvato in:
| Pubblicato in: | Degener Neurol Neuromuscul Dis |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Dove Medical Press
2012
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6065567/ https://ncbi.nlm.nih.gov/pubmed/30890881 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DNND.S16087 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|